Studying the natural history of frontotemporal lobar degeneration (FTLD): The ARTFL LEFFTDS longitudinal FTLD (ALLFTD) protocol: Neuropsychiatry and behavioral neurology: DLB and FTD — clinical manifestations. (7th December 2020)

• Record Type: Journal Article
• Authors: Boeve, Bradley F.; Boxer, Adam L.; Rosen, Howard J.; Forsberg, Leah K.; Heuer, Hilary W.; Brushaber, Danielle; Appleby, Brian; Biernacka, Joanna M.; Bordelon, Yvette M.; Botha, Hugo; Brannelly, Patrick; Dickerson, Brad C.; Dickson, Dennis W.; Kimiko, Domoto‐Reilly; Faber, Kelley; Fagan, Anne; Fields, Julie A.; Fishman, Ann; Foroud, Tatiana M.; Galasko, Doug R.; Gavrilova, Ralitza H.; Gendron, Tania F.; Geschwind, Daniel H.; Ghoshal, Nupur; Goldman, Jill; Graff‐Radford, Jonathan; Graff‐Radford, Neill R.; Grant, Ian; Grossman, Murray; Hsiung, Ging‐Yuek Robin; Huang, Eric J.; Huey, Edward; Irwin, David J.; Jones, David T.; Kantarci, Kejal; Karydas, Anna M.; Kaufer, Daniel; Knopman, David S.; Kramer, Joel H.; Kremers, Walter K.; Kornak, John; Kukull, Walter A.; Lagone, Emma; Leger, Gabriel C.; Litvan, Irene; Ljubenkov, Peter A.; Lucente, Diane E; Mackenzie, Ian R; Manoochehri, Masood; Masdeu, Joseph C.; McGinnis, Scott; Mendez, Mario F.; Miller, Bruce L.; Miyagawa, Toji; Nelson, Kevin M.; Onyike, Chiadi U; Pantelyat, Alex; Pascual, Belen; Pearlman, Rodney; Petrucelli, Leonard; Rademakers, Rosa; Ramos, Eliana Marisa; Rankin, Katherine; Rascovsky, Katya; Rexach, Jessica E.; Ritter, Aaron; Roberson, Erik D.; Rojas, Julio C.; Sabbagh, Marwan N.; Salmon, David P.; Savica, Rodolfo; Seeley, William W.; Staffaroni, Adam M.; Syrjanen, Jeremy; Tartaglia, Carmela; Tatton, Nadine; Taylor, Joanne; Toga, Arthur W.; Weintraub, Sandra; Wheaton, Diana; Wong, Bonnie; Wszolek, Zbigniew;
• Is Part Of: Alzheimer's & dementia. Volume 16(2020)Supplement 6
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-12-07
• Subjects: Alzheimer's disease -- Periodicals; Alzheimer Disease -- Periodicals; Dementia -- Periodicals; Démence; Maladie d'Alzheimer; Périodique électronique (Descripteur de forme); Ressource Internet (Descripteur de forme); 616.83
• DOI: 10.1002/alz.045482
• Languages: English
• ISSNs: 1552-5260

Abstract

Abstract: Background: It is important to determine the natural history of sporadic and familial frontotemporal lobar degeneration (FTLD) and generate clinical, neuropsychological, neuroimaging and biofluid data for planning disease‐modifying trials. Method: As part of the ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD; U19 AG063911) protocol, investigators at 19 centers in North America will enroll 2100 participants with FTLD over the next 5 years beginning in early 2020. Result: As of 1/20/20, the ARTFL/LEFFTDS (A/L) Consortium had enrolled 1832 participants, including 850 in kindreds with familial FTLD (239 associated with mutations in MAPT, 192 in GRN, 370 in C9orf72, 4 with mutations in both GRN and C9orf72, and 45 with a mutation in a different gene or no mutation in any known FTLD‐associated gene). Over 500 participants have undergone 2 or more annual visits to date. MRI has been performed in 1105. Biofluid samples have also been collected, with blood (DNA, plasma, serum, mRNA, PBMC) in 1413 and CSF in 303. Over 60 manuscripts using A/L data or samples have been published to date. Five clinical trials involving A/L and ALLFTD participants are in progress or planned. The longitudinal arm in ALLFTD will enroll 500 of existing A/L and 600 future participants for annual assessments with similar methodology to A/L. An additional 1000 FTLD patients will undergo focused one‐time clinical evaluations and biofluid collection. Conclusion: The data/samples from already‐enrolled and planned participants in ALLFTD and findings published to date underscore the utility of evaluating FTLD subjects. The absence of identifiable mutations in some with familial FTLD suggests that other genes are yet to be discovered. ALLFTD data will inform clinical trial design, and many participants will be eligible for future trials. The key data and samples in ALLFTD are available to interested investigators worldwide. Supported by: AG063911, AG045390, NS092089, AG016976, AG21886.